# FAM169A

## Overview
FAM169A is a gene that encodes a member of the protein family with sequence similarity 169 member A. This protein is involved in various cellular processes, although its specific functions are not fully elucidated. The gene has garnered attention due to its role in pathological conditions such as intervertebral disc degeneration (IDD) and ovarian cancer. In IDD, the circular RNA form of FAM169A, known as circ-FAM169A, is implicated in the degradation of the extracellular matrix, contributing to disease progression through the NF-κB signaling pathway (Guo2020The). In ovarian cancer, circFAM169A acts as a competing endogenous RNA, influencing cancer cell proliferation by modulating the p38/MAPK signaling pathway (Fu2023ncRNAs). These findings suggest that FAM169A and its circular RNA form may serve as potential therapeutic targets in these diseases.

## Clinical Significance
FAM169A has been implicated in intervertebral disc degeneration (IDD), a condition that leads to low back pain. The circular RNA form of FAM169A, known as circ-FAM169A, is significantly upregulated in degenerative nucleus pulposus tissues. This upregulation contributes to IDD by enhancing extracellular matrix (ECM) catabolism and suppressing ECM anabolism, leading to increased degradation of ECM components such as collagen II and aggrecan, and elevated levels of matrix metalloproteinase-13 (MMP-13) and ADAMTS-5. Circ-FAM169A acts as a competitive endogenous RNA by sponging miR-583, which results in the upregulation of BTRC, a component involved in the NF-κB signaling pathway. This pathway is associated with inflammatory responses and ECM degradation, further contributing to IDD progression (Guo2020The).

In ovarian cancer, circFAM169A functions as a competing endogenous RNA that sponges miR-106a-5p and miR-519d-3p, facilitating the expression of RPS6KA2. This interaction is significant as RPS6KA2 is shown to inhibit ovarian cancer cell proliferation via the p38/MAPK signaling pathway, suggesting that circFAM169A could serve as a potential target for ovarian cancer treatment (Fu2023ncRNAs).


## References


[1. (Fu2023ncRNAs) Zhiqin Fu, Chao Ding, Wangang Gong, and Chao Lu. Ncrnas mediated rps6ka2 inhibits ovarian cancer proliferation via p38/mapk signaling pathway. Frontiers in Oncology, January 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1028301, doi:10.3389/fonc.2023.1028301. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1028301)

[2. (Guo2020The) Wei Guo, Kun Mu, Bin Zhang, Chao Sun, Ling Zhao, Zhan-Yin Dong, and Qing Cui. The circular rna fam169a functions as a competitive endogenous rna and regulates intervertebral disc degeneration by targeting mir-583 and btrc. Cell Death &amp; Disease, May 2020. URL: http://dx.doi.org/10.1038/s41419-020-2543-8, doi:10.1038/s41419-020-2543-8. This article has 32 citations.](https://doi.org/10.1038/s41419-020-2543-8)